Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial - Fakhouri, F; Hourmant, M; Campistol, JM (Am J Kidney Dis, 2016)
et al.